| Literature DB >> 35309870 |
Anke Erdmann1, Celia Spoden2, Irene Hirschberg3, Gerald Neitzke3.
Abstract
Amyotrophic lateral sclerosis (ALS) leads to death on average 2-4 years after the onset of symptoms. Although many people with the disease decide in favour of life-sustaining measures, some consider hastening death. The objectives of this review are to provide an insight into the following questions: (1) How do people with amyotrophic lateral sclerosis (PALS), their families and health care professionals (HCPs) communicate about life-sustaining and life-shortening options? (2) What are the challenges for all involved in decision making and communication about this topic? To answer these questions, we searched eight databases for publications in English and German on end-of-life issues of PALS. We included texts published between 2008 and 2018, and updated our search to May 2020. Sources were analysed in MAXQDA using deductively and inductively generated codes. After the final analysis, 123 full texts were included in this review. We identified a wide range of communicative challenges and six different and, in part, opposite communication patterns: avoiding or delaying communication on end-of-life issues, openly considering dying and actively seeking assistance, ignoring or disregarding patients' wishes, discussing and respecting the patients' wishes, engaging in advance care planning and avoiding or delaying advance care planning. The literature reveals a very heterogeneous response to end-of-life issues in ALS, despite several good-practice suggestions, examples and guidelines. We derive a strong need for harmonization and quality assurance concerning communication with PALS. Avoiding or delaying communication, decision making and planning, as well as ignoring or disregarding the patient's will by HCP can be judged as a violation of the ethical principles of autonomy and non-maleficence.Entities:
Keywords: advance care planning; assisted suicide; communication strategies; end-of-life decision making; euthanasia; wish to hasten death
Year: 2022 PMID: 35309870 PMCID: PMC8928370 DOI: 10.1177/26323524221083676
Source DB: PubMed Journal: Palliat Care Soc Pract ISSN: 2632-3524
Search strategy.
| Databases | Algorithm | Records |
|---|---|---|
| PubMed | ((‘amyotrophic lateral sclerosis’ (Title/Abstract) OR ‘motor neuron disease’ (Title/Abstract) OR ‘motor neurone disease’ (Title/Abstract) OR ‘ALS’ (Title/Abstract) OR ‘MND’ (Title/Abstract)) AND (‘hasten death’ OR ‘hastening death’ OR withhold* OR withdraw* OR euthanasia OR suicide OR (‘decision-making’ AND ‘end of life’) OR (‘palliative care’ AND ethics) OR (‘mechanical ventilation’ AND ethics) OR ‘advance care planning’ OR ‘advance directives’)) NOT (placebo OR mouse OR rat OR ‘animal model’) | 854 + 187 |
| LIVIVO – The Search Portal for Life Sciences | ((‘amyotrophic lateral sclerosis’ OR ‘motor neuron disease’ OR ‘motor neurone disease’ OR ‘ALS’ OR ‘MND’) AND (‘hasten death’ OR ‘hastening death’ OR withhold* OR withdraw* OR euthanasia OR suicide OR (‘decision-making’ AND ‘end of life’) OR (‘palliative care’ AND ethics) OR (‘mechanical ventilation’ AND ethics) OR ‘advance care planning’ OR ‘advance directives’)) NOT (placebo OR mouse OR rat OR ‘animal model’) | 314 + 86 |
| BELIT | (‘amyotrophic lateral sclerosis’ OR ‘motor neuron disease’ OR ‘motor neurone disease’ OR ‘MND’) | 121 + 4 |
| CareLit | ‘Amyotrophe Lateralsklerose’ OR ‘Motoneuronerkrankung’ | 17 + 18 |
| Total | 1306 + 295 = 1601 |
Figure 1.Review process.
Overview of text types and study designs included.
| Text type/study design | Number of references in the entire review | Number of references in this analysis |
|---|---|---|
| Quantitative studies | 56 | 25 |
| Qualitative studies | 39 | 26 |
| Mixed methods | 9 | 7 |
| Reviews | 43 | 21 |
| Case studies | 16 | 11 |
| Commented cases | 9 | 5 |
| Personal experience and case reports | 29 | 21 |
| Guidelines and guidance | 6 | 5 |
| Editorials | 6 | 2 |
| Total | 213 | 123 |
Challenges for patients, family members and HCPs identified in the publications.
| Topics | Challenges identified in the publications |
|---|---|
| Illness progression and coping | Discussing concerns about illness progression
|
| Different information needs of patients depending on their coping with the illness[ | |
| Considering family members’/dependents’ (different) psychosocial needs and wishes,[ | |
| Anticipating suffering in later stages of the illness
| |
| Changing perceptions of the quality of life, and of life and death wishes
| |
| Changing preferences regarding therapy options
| |
| To be asked for an exact prognosis
| |
| Decision making | Discussing end-of-life issues/decisions,[ |
| Discussing decisions for life-sustaining therapy options,[ | |
| Lack of decision making by the patient
| |
| Different opinions between patients, families
| |
| Finding out the patient’s will when the patient is no longer able to communicate (orally or with eye movements)[ | |
| Identifying cognitive deficits
| |
| Deciding for or against life-sustaining measures in an emergency situation (e.g. tracheotomy) if the patient does not have an advance (care) directive
| |
| Deciding whether to call an ambulance in emergency situations if the patient wants to die at home
| |
| Dealing with wishes to die | Being confronted with wishes to die early after diagnosis
|
| Withdrawal of mechanical ventilation is practically, emotionally
| |
| Receiving a request for assisted suicide provokes a sense of hopelessness and failure
| |
| Predicting only 6 months survival before the prescription of drugs for assisted suicide
| |
| Confrontation with one’s own (professional) attitudes, perceptions and values, especially regarding PALS’ wishes to die and therapy options
| |
| Insufficient health care system and care options or inexperienced HCP[ |
HCPs, health care professionals; PALS, people with amyotrophic lateral sclerosis.
The topics in the first column do not present codes of data analysis but were developed afterwards in order to categorize the challenges. Superscripts refer to the publication that contained the challenge described. Some publications did not clearly specify which of the groups concerned faced the challenge. We had difficulties in consistently assigning these challenges to the three groups of people. In our opinion, it would be also misleading, because if a challenge is reported for one group, the challenge may well exist for another group, although we did not find any evidence of this.
Reasons to avoid or delay conversation about life-sustaining or life-shortening options.
| Actors | Reasons and motives for avoiding or delaying | Publications |
|---|---|---|
| Patients and families | Denial as a coping strategy | National Clinical Guideline Centre,
|
| Associating death with a loss of hope and a negative attitude | Ray | |
| Family members wanting to ‘protect’ the patient by withholding information about the true medical condition | Ushikubo
| |
| Health care professionals | Assumption of a negative quality of life | Lulé |
| Fear of ethical conflicts or legal consequences | Khin Khin | |
| Paternalistic approach | Mattulat
| |
| Legal status of advance directive unclear | Connolly
|
Possible reasons of PALS for avoiding or delaying an AD.
| Reasons and motives of PALS to avoid or delay the completion of an AD | Publications |
|---|---|
| Denial as coping strategy (‘living in the moment’) | LeBon and Fisher,
|
| Doubts about the benefits of an AD | Whitehead |
| Drafting an AD can be perceived as a decision between life and death | Danel-Brunaud |
| Cognitive impairment is not expected by PALS | Burchardi |
| Hope for recovery | Burchardi |
| Difficulties to anticipate suffering in advanced stages of the illness lead to vague formulations in the AD | Burchardi |
AD, advance directive; PALS, people with amyotrophic lateral sclerosis.